News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Professor Axel Behrens elected as Fellow of the Academy of Medical Sciences
Professor Axel Behrens, Scientific Director of the Cancer Research UK Convergence Science Centre and leader of the Cancer Stem Cell Group at The Institute of Cancer Research, London, has been awarded a prestigious Fellowship by the Academy of Medical Sciences.
Researchers identify what drives PARP inhibitor resistance in advanced breast cancer
Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This research could ultimately help predict who’s more likely to respond to these drugs, and could lead to more effective ways to treat the disease.
New trial finds radiotherapy combined with hormone therapy can help some advanced prostate cancer patients avoid chemotherapy
Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, according to researchers from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
Immune cells hunt down cancer around the body – discovery could lead to personalised treatments for advanced breast cancer
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a different part of the body.
New screening trial to save thousands of men’s lives from prostate cancer
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate cancer and double the number of lives saved.
ICR researcher wins prestigious clinical science award
Dr Stephen-John Sammut, a Clinician Scientist at the ICR, and Consultant in Medical Oncology at The Royal Marsden, has been awarded the Graham Bull Prize by the Royal College of Physicians for his work in personalised breast cancer medicine.
Scientists uncover promising new treatment strategy for aggressive form of leukaemia
Scientists have uncovered a promising treatment strategy for an aggressive type of leukaemia – through targeting the enzymes that cells normally use to sense and adapt to changing oxygen levels.
Shape-shifting cancer cell discovery reveals two potential drug targets against skin cancer
Scientists have discovered how skin cancer cells shapeshift based on their environment – enabling them to spread through the body and cause a metastatic cancer.
Ride announced in memory of Hairy Biker Dave Myers to support The Institute of Cancer Research
The Institute of Cancer Research, London, is honoured to be a beneficiary of a motorbike ride in tribute to Dave Myers of the Hairy Bikers. The ride will take place on Saturday 8 June 2024.
Scientists find new ways to convert inhibitors into degraders, paving the way for future drug discoveries
Researchers have discovered ways to convert inhibitor-style targeted cancer drugs into small molecules known as degraders, which help destroy cancer-promoting proteins in cells.
Groundbreaking methodological advance will support the design of innovative new cancer drugs
Scientists have successfully used a new imaging technique to determine the structure and interactions of a protein complex that plays a significant part in the initiation and progression of cancer.
Research uncovers how to target ‘sleeping’ breast cancer cells and prevent relapse
Scientists have discovered how breast cancer cells can ‘hibernate’ to avoid treatment and ‘wake up’ years later – causing a relapse that is more difficult to treat.
